Soren Aasmul

This inventor holds 16 USPTO granted patents and 4 published patent applications, plus 10 CIPO patents and 8 EPO patents, primarily in Sensor Systems. Top assignees: Medtronic Minimed, Inc., Nna/s, Novo Nordisk A/s. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soren Aasmul. Retrieved from https://idiyas.com/inventor/soren-aasmul

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 16 (Patent Applications = 4)

% Patents Active = 87.5

CIPO Patents = 10

EPO Patents = 8 (Patent Applications = 9)

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 416(Granted Patents)

Company Filing History:

13 out of 1,270

Medtronic Minimed, Inc.

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Orthogonal Redundancy

Optical Glucose Assays

Biostable Polymers

Radiation Protection

Phase Shift Measurement

Drug Delivery Devices

Glucose Permeable

Sensor Interface

Medical Self Treatment

Modified-Dextrans

Aqueous Formulations

User Assistance

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12773138 - Orthogonally redundant sensor systems and methods (2026-10-27),

2. 11931145 - Orthogonally redundant sensor systems and methods (2024-03-19),

3. 11229384 - Orthogonally redundant sensor systems and methods (2022-01-25),

4. 10864286 - Modified-dextrans for use in optical glucose assays (2020-12-15),

5. 10792378 - Using a blue-shifted reference dye in an optical glucose assay (2020-10-06),

6. 10543288 - Modified-dextrans for use in optical glucose assays (2020-01-28),

7. 10194845 - Orthogonally redundant sensor systems and methods (2019-02-05),

8. 9936905 - Sensor with optical interface (2018-04-10),

9. 9848805 - Biostable glucose permeable polymer (2017-12-26),

10. 9642568 - Orthogonally redundant sensor systems and methods (2017-05-09),

11. 9421287 - Methods for making an aqueous radiation protecting formulation (2016-08-23),

12. 8999720 - Aqueous radiation protecting formulations and methods for making and using them (2015-04-07),

13. 8080810 - Method and apparatus for measuring the phase shift iduced in a light signal by a sample (2011-12-20),

14. 7884338 - Method and apparatus for measuring the phase shift induced in a light signal by a sample (2011-02-08),

15. 7282029 - Method and a system for assisting a user in a medical self treatment, said self treatment comprising a plurality of actions (2007-10-16),

Title: **Innovative Mind: The Story of Soren Aasmul**

Introduction

Soren Aasmul, an accomplished inventor based in Holte, Denmark, has made significant contributions to the field of technology, particularly in the area of glucose monitoring systems. With a remarkable portfolio of 15 patents, Aasmul stands out for his innovative approaches and dedication to improving healthcare technologies.

Latest Patents

Among his most notable patents is the development of orthogonally redundant sensor systems and methods for continuous glucose monitoring. This inventive system incorporates a hand-held monitor, a transmitter, and an insulin pump, all part of an advanced glucose sensor network. The system features both an optical glucose sensor and a non-optical electrochemical sensor, with the optical sensor utilizing a fiber-optic mechanism for detecting glucose levels through a competitive binding affinity assay. The non-optical sensor consists of electrodes designed to provide accurate glucose measurements. These sensors work in tandem, ensuring reliability by being co-located within the user’s body, allowing precise monitoring through a single delivery needle.

Career Highlights

Soren Aasmul's impressive career has included significant roles at leading companies such as Medtronic Minimed, Inc. and Novo Nordisk A/S. His work with these organizations has fortified his expertise in the field of medical devices, particularly in enhancing patient care through innovative technologies. Aasmul's contributions have not only led to advancements in glucose monitoring but also to breakthroughs in other health-related technologies.

Collaborations

Throughout his career, Soren has collaborated with notable individuals such as Jesper Svenning Kristensen and Rajiv Shah. Their collective efforts in innovation have helped drive forward-thinking solutions in the medical technology sector, paving the way for future advancements.

Conclusion

Soren Aasmul exemplifies the spirit of innovation with his dedication to developing technologies that significantly impact healthcare. His work in glucose monitoring systems reflects a commitment not only to invention but also to improving quality of life for individuals living with diabetes. As he continues to build upon his extensive patent portfolio, Aasmul remains a key figure in the ever-evolving landscape of medical innovation.

Profile summary based on public USPTO records.